These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34633646)

  • 1. Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries.
    Norby FL; Lutsey PL; Shippee ND; Chen LY; Henning-Smith C; Alonso A; Walker RF; Folsom AR
    Am J Cardiovasc Drugs; 2022 Mar; 22(2):207-217. PubMed ID: 34633646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
    Chen N; Brooks MM; Hernandez I
    JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation.
    Thunell J; Wood K; Wharton W; Joyce G; Ferido P; Zissimopoulos J
    Neurology; 2024 Jul; 103(1):e209568. PubMed ID: 38857466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas.
    Guo J; He M; Magnani JW; Brooks MM; Gellad WF; Hernandez I
    Am J Cardiol; 2020 Sep; 130():64-69. PubMed ID: 32680675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
    Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
    JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.
    Ardeshirrouhanifard S; An H; Goyal RK; Raji MA; Segal JB; Alexander GC; Mehta HB
    Pharmacotherapy; 2022 May; 42(5):375-386. PubMed ID: 35364622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees.
    Wong ES; Done N; Zhao M; Woolley AB; Prentice JC; Mull HJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1056-1066. PubMed ID: 34337995
    [No Abstract]   [Full Text] [Related]  

  • 9. Veterans Affairs Medical Center Racial and Ethnic Composition and Initiation of Anticoagulation for Atrial Fibrillation.
    Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Litam TMA; Boyer TL; Gellad WF; Fine MJ
    JAMA Netw Open; 2024 Jun; 7(6):e2418114. PubMed ID: 38913375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
    Alalwan AA; Voils SA; Hartzema AG
    Am J Health Syst Pharm; 2017 Aug; 74(16):1237-1244. PubMed ID: 28652320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
    Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
    Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.
    Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R
    JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.
    Reyes JL; Herzog CA; Yan H; Roetker NS; Wetmore JB
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221142220. PubMed ID: 36472155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
    Navar AM; Kolkailah AA; Overton R; Shah NP; Rousseau JF; Flaker GC; Pignone MP; Peterson ED
    J Am Heart Assoc; 2022 Nov; 11(22):e026723. PubMed ID: 36346063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
    Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
    Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
    Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
    Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.